Pear Therapeutics, Inc.
200 State Street, 13th Floor
Boston, Massachusetts 02109
December 29, 2021
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Pear Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-261876 Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pear Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-261876) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on December 30, 2021, or as soon thereafter as practicable.
[Remainder of this page intentionally left blank]
Very truly yours, PEAR THERAPEUTICS, INC. | |||||
By: | /s/ Ronan O’Brien | ||||
Name: Ronan O’Brien Title: General Counsel |
[Signature Page to Pear Therapeutics, Inc. Acceleration Request]